Weikaier Pharmaceutical Technology Co., Ltd. is based on the research and development of innovative drugs, the transfer of generic drug technology, and the production and sales of pharmaceutical intermediates. Recently announced the completion of A2 round of financing. So far, Jiangsu Weikaier’s A round of financing has come to an end, with a total financing of nearly 60 million US dollars. This round of financing was continued to be supported by SDIC Investment, and jointly invested with Changjiang Industrial Investment.
This article is reproduced from: https://www.itjuzi.com/investevent/13184625
This site is for inclusion only, and the copyright belongs to the original author.